| Tag | Content |
|---|
EnhancerAtlas ID | HS020-26558 |
Organism | Homo sapiens |
Tissue/cell | CD34+ |
Coordinate | chr2:216544660-216546990 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Gata1 | MA0035.3 | chr2:216546475-216546486 | AGAGATAAGGA | - | 6.02 | | IRF1 | MA0050.2 | chr2:216545601-216545622 | GAGAGAAAAGTGAAACAAATA | - | 6.13 | | MITF | MA0620.2 | chr2:216546738-216546756 | GAGGGTCACATGACTTCA | + | 6.13 | | MITF | MA0620.2 | chr2:216546738-216546756 | GAGGGTCACATGACTTCA | - | 6.13 | | Stat6 | MA0520.1 | chr2:216546819-216546834 | CATTTCTTGAGAACT | + | 7.19 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_02680 | chr2:216545306-216547009 | Astrocytes | | SE_45570 | chr2:216544833-216547498 | Osteoblasts | | SE_55663 | chr2:216543789-216547470 | u87 | | SE_67699 | chr2:216543789-216547470 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I215680 | chr2 | 216545057 | 216547522 |
|
Enhancer Sequence | TTTCTTTCTG TCGCATTACC TGCTTAACAA TTGTTCTTTA AAATGTTGTG TACAGTAGAT 60
ATTATTTACA TCCTTAGTGT TTTTATGTTT CCCAATTACA ATGTGGGTAA TTCAATTCTT 120
TCATCGTTAA TAGAAATTAG ATAAGAAGAA GAATCTGTAA ATTTCTGAAT TCAATTTTAT 180
AAAGTACATT AGAAATATTA AATATCTAGA ATTGTAGCAT TTTGAAATTA TGTAAAAACA 240
TAATTATTAC AAAATCATGA ATGGAAATTC AGGTCCTTTA CATTTTGTGG GCTATAAATA 300
TTCAGAAAAA TTTTAGAAGT TGATGTTCCT CGATGAGAAC ACATGGACAC CTGGGAGGGG 360
AACAACACAC ACTGGGGTCT GACGGCGGGG GCGGGGGAGG GAGAGCATCA GGAAGAACAG 420
CTAAGGGATG CTGGGCTTAA TACCTAGGGG ATGAGTTGAT CTGTGCAGCA AACCACCATG 480
CCCCACGTTT ACCTACGTAA CAAACCTGCA CATCCCTCAC ATGTATCTCG GAACTTAAAA 540
TGAAAATTGA TTAAAAAAAA AGAATAAAAG TAGAGATGAA AGAAATGGAT GTTCCTAAAA 600
GAAACAACAG ATACCTTTTA AAATACACTT TCAGTATAAC TAAGTACCTT TTCAAGTTGG 660
TTAAAAAATT CTAAAAGTAG AGTAGTCAAG TCCTTAAGTA ACATGACGAT CCTATCTACA 720
GTTTAAATAA ATGTTCAGTC ATCCCAACAG GAACAAATCA TAAAGAAAAT GTAAAGAATA 780
TATCAAATTG GCTAAATGCA TTCTATATTC GTAGTGTACT CACTGAAGCA TTGTTCGTGG 840
GTTTTTTTTT TCTGATTCTT ACCAAGCCTA CATATTTCTT TTTAATTTTT TCTTTTTATG 900
TTTCCCAAGT TTACAGTTCA CATAAAATAC CCACTGAAGC AGAGAGAAAA GTGAAACAAA 960
TATTTCACAG CTCTTTGGGG ATTTGAATGG GTTTTTACAA TAAAACCTTG ATTACTCAAA 1020
GAGCACAGGA GTGCCTGAAA CCTGATAGAA GGAACAGAGA GCAGGCAGTT CTAAAGGTGC 1080
CAAGAGAGAC TCAGAACCTT GTGGAGTTGA TGCACTGGCC CTTCAACCCT GGAACCCAGG 1140
CCAAGCACCA AACCAGGAAG GGTCCAAACA GCCCTGAACA TGGCTATCGT GGCCAAACAA 1200
ACCAAAAAAA AAAAAGTCAC TTGGAAAAGA TGTGCAAGGT TGTGGTTTCC TGATAAATTA 1260
AGATGACACA GGCAGTACCA CAGGGCTTCC TTCATTACAT TATTGTGAAA TCTGGACTCA 1320
AATAGAATGA GGCAAACCCA CAAGTTAAAG TGTTTTTAAA GTGGCTCAAT AATCACTTTG 1380
AAAACAGAAC ACCCTTTCAG TCAGCATGAC TGGAACTTTG ATCAACAAAT CCCCAAGAGC 1440
CACAACCCGT CTTTTGTGAA CAAGTAGTAT CAAGGTGGGG GTGGGCTTGG AGTGCACTGG 1500
ATGCTTTTCT TCTTTCATCA TGAAACCTGG TGGTTTTGTG TCATGTGATA TGTTTTTCAG 1560
AGATTCGGCA GGAAGCTTGC ACCGAGTGAA GGATTTATAA AGATTATAGG AGATAACACA 1620
AAGCTATTTT ATCTCTTTAA AAAAAATCAA AGGTATTAAA TTTTTTTCTA CTTCATTTTT 1680
GTTTCCTCAT TTAAAAATTA GCTGCCACAA ATATTATCCC CCATCTGGGC ACAAGGTCAG 1740
TTGGCATACA ATTTTCTTCT TAATTTTCAT TTTCTGGATT CCTTGATGAC CTGATTTTGT 1800
ACAAATTCAT GCTGCAGAGA TAAGGATTGA TTGGCTACAA ATCAAGGATC TCTGCAGAAT 1860
GGGAATGAGA GACAAAGGAA GAGGAAGAGG ACGGACACCA CAAACCATCT TATCTTTTCA 1920
AAATGTGATT GGTGCATTTT CAACATTGGC TTACCTTTCC TTATGCTGTC CATAAATTTT 1980
GTGCAGGTGT AAGCTCATCC TACACATGTC ATTTGGACCA GACCAAGGCT GCTGTCATGG 2040
AGGACCCACA CCACAGCTTG GGAACCATTC ATCTACCAGA GGGTCACATG ACTTCAAATG 2100
ACTCTTCTAG GGGCCACCTG CCATGATAGG GTACCAGCTC TTCCTCTGAA TTCCCAATCC 2160
ATTTCTTGAG AACTACTGTT TCTAATAAGG TACTGTTTCT AATACCTTTC CAACAATGGT 2220
TTATTCATTT ATCCATACAT TTAAAATACA GATTTTTTTT AGCATCTGCC ATGTTTAAGA 2280
TCCTCCTCTA GCACTAGGAA TACATTATTG AATAGAACAA AGTCCCTGAT 2330
|
